seropositivity to tumour antigens as a potential new biomarker for melanoma relapse
Published 8 years ago • 102 plays • Length 3:28Download video MP4
Download video MP3
Similar videos
-
34:09
why is ctdna important as a biomarker for melanoma?
-
1:13
dr. polsky on using ctdna as a biomarker for melanoma
-
25:41
new immunotherapies, precision medicine and biomarkers in melanoma
-
1:15
dr. hamid on tmb as a biomarker for immunotherapy response in melanoma
-
1:57
yardena samuels on rasa2 as prognostic biomarker in melanoma
-
4:42
biomarker sampling in metastatic melanoma
-
1:19
dr. hamid on using biomarkers for immunotherapy in melanoma
-
42:29
advanced melanoma
-
40:35
biomarkers lighting the way
-
2:58
the importance of biomarkers to optimize treatment with immunotherapy for melanoma
-
2:53
opacin-neo: tmb and ifn-γ identified as biomarkers of pathologic response in melanoma
-
29:39
history of melanoma immunotherapy - from freund to ipilimumab
-
6:33
sargramostim and icis: combinatorial therapeutic studies in metastatic melanoma – video abstract
-
2:13
next steps in validating glycosylated proteins as biomarkers for melanoma treatment response
-
25:44
the latest treatments for melanoma - an overview
-
16:58
assessing immune biomarkers of response to anthracyclines in breast cancer
-
24:18
immunotherapy biomarkers and patient selection
-
1:03:55
the nuances of immunotherapy biomarker testing in solid tumors
-
31:50
predictive biomarkers of checkpoint blockades with keith flaherty, md